858
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Uptake of poly-dispersed single-walled carbon nanotubes and decline of functions in mouse NK cells undergoing activation

, &
Pages 758-765 | Received 23 Feb 2016, Accepted 16 May 2016, Published online: 14 Jul 2016

References

  • Aktas E, Kucuksezer UC, Bilgic S, Erten G, Deniz G. 2009. Relationship between CD107a expression and cytotoxic activity. Cell Immunol. 254:149–154.
  • Alam A, Sachar S, Puri N, Saxena RK. 2013. Interactions of poly-dispersed single-walled carbon nanotubes with T-cells resulting in downregulation of allogeneic CTL responses in vitro and in vivo. Nanotoxicology. 7:1351–1360.
  • Alter G, Malenfant JM, Altfeld M. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Meth. 294:15–22.
  • Andersen AJ, Wibroe PP, Moghimi SM. 2012. Perspectives on carbon nanotube-mediated adverse immune effects. Adv Drug Deliv Rev. 64:1700–1705.
  • Becker AM, Blevins JS, Tomson FL, Eitson JL, Medeiros JJ, Yarovinsky F, Norgard MV, van Oers NS. 2010. Invariant NKT cell development requires a full complement of functional CD3 zeta immunoreceptor tyrosine-based activation motifs. J Immunol. 184:6822–6832.
  • Bhardwaj N, Saxena RK. 2015. Selective loss of younger erythrocytes from blood circulation and changes in erythropoietic patterns in bone marrow and spleen in mouse anemia induced by poly-dispersed single wall carbon nanotubes. Nanotoxicology. 9:1032–1040.
  • Bossi G, Griffiths GM. 1999. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T-cells and natural killer cells. Nat Med. 5:90–96.
  • Bryant J, Day R, Whiteside TL, Herberman RB. 1992. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Meth. 146:91–103.
  • Caligiuri MA. 2008. Human natural killer cells. Blood. 112:461–469.
  • Cantor H, Kasai M, Shen FW, Leclerc JC, Glimcher L. 1979. Immunogenetic analysis of “natural killer” activity in the mouse. Immunol Rev. 44:3–12.
  • Cerottini JC, Engers HD, Macdonald HR, Brunner KT. 1974. Generation of cytotoxic T-lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed Leukocyte cultures. J Expert Med. 140:703–717.
  • Craston R, Koh M, Mc Dermott A, Ray N, Prentice HG, Lowdell MW. 1997. Temporal dynamics of CD69 expression on lymphoid cells. J Immunol Meth. 209:37–45.
  • Cui HF, Vashist SK, Al-Rubeaan K, Luong JH, Sheu FS. 2010. Interfacing carbon nanotubes with living mammalian cells and cytotoxicity issues. Chem Res Toxicol. 23:1131–1147.
  • Delogu LG, Venturelli E, Manetti R, Pinna GA, Carru C, Madeddu R, Murgia L, Sgarrella F, Dumortier H, Bianco A. 2012. Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine (London). 7:231–243.
  • Dumortier H. 2013. When carbon nanotubes encounter the immune system: desirable and undesirable effects. Adv Drug Deliv Rev. 65:2120–2126.
  • Guidotti LG, Chisari FV. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol. 19:65–91.
  • Hochreiter-Hufford A, Ravichandran KS. 2013. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harbor Perspect Biol. 5:a008748.
  • Kagi D, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol. 14:207–232.
  • Kostarelos K, Lacerda L, Pastorin G, Wu W, Wieckowski S, Luangsivilay J, Godefroy S, Pantarotto D, Briand J, Muller S, et al. 2007. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat Nanotechnol. 2:108–113.
  • Kumari M, Sachar S, Saxena RK. 2012. Loss of proliferation and antigen presentation activity following internalization of poly-dispersed carbon nanotubes by primary lung epithelial cells. PLoS One. 7:e31890.
  • Laverny G, Casset A, Purohit A, Schaeffer E, Spiegelhalter C, de Blay F, Pons F. 2013. Immuno-modulatory properties of multi-walled carbon nanotubes in peripheral blood mononuclear cells from healthy subjects and allergic patients. Toxicol Lett. 217:91–101.
  • Mace EM, Dongre P, Hsu HT, Sinha P, James AM, Mann SS, Forbes LR, Watkin LB, Orange JS. 2014. Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunol Cell Biol. 92:245–255.
  • Marzio R, Mauël J, Betz-Corradin S. 1999. CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol. 21:565–582.
  • Mitchell LA, Lauer FT, Burchiel SW, McDonald JD. 2009. Mechanisms for how inhaled multi-walled carbon nanotubes suppress systemic immune function in mice. Nat Nanotechnol. 4:451–456.
  • Miyake T, Kumagai Y, Kato H, Guo Z, Matsushita K, Satoh T, Kawagoe T, Kumar H, Jang MH, Kawai T, et al. 2009. Poly(I:C)-induced activation of NK cells by CD8α+ dendritic cells via the IPS-1 and TRIF-dependent pathways. J Immunol. 183:2522–2528.
  • Oberdörster T, Castranova V, Asgharian B, Sayre P. 2015 Inhalation exposure to carbon nanotubes (CNT) and carbon nanofibers (CNF): Methodology and dosimetry. J Toxicol Environ Health 18:121–212.
  • Orecchioni M, Bedognetti D, Sgarrella F, Marincola FM, Bianco A, Delogu LG. 2014. Impact of carbon nanotubes and graphene on immune cells. J Transl Med. 12:138.
  • Reefman E, Kay JG, Wood SM, Offenhäuser C, Brown DL, Roy S, Stanley AC, Low PC, Manderson AP, Stow JL. 2010. Cytokine secretion is distinct from secretion of cytotoxic granules in NK cells. J Immunol. 184:4852–4862.
  • Rizvi ZA, Puri N, Saxena RK. 2014. Lipid antigen presentation through CD1d pathway in mouse epithelial cells, macrophages and dendritic cells and its suppression by poly-dispersed single walled carbon nanotubes. Toxicol In Vitro. pii:S0887-2333(14)00213–6.
  • Sachar S, Saxena RK. 2011. Cytotoxic effect of poly-dispersed single walled carbon nanotubes on erythrocytes in vitro and in vivo. PLoS One. 6:e22032.
  • Salem ML, Al-Khami AA, El-Nagaar SA, Zidan AA, Al-Sharkawi IM, Marcela Díaz-Montero C, Cole DJ. 2012. Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide. Cell Immunol. 276:67–74.
  • Saxena RK. 1996. Understanding inverse correlation between the levels of Class I Major Histocompatibility Complex antigens on tumor cells and their susceptibility to natural killer cells: Evidence of competition experiments. Curr Sci. 70:143–146.
  • Saxena RK. 1997. Ontogeny of inhibitory receptors for MHC molecules on NK cells. Immunol Today. 18:146–147.
  • Saxena RK, Alder WH, Nordin AA. 1981. Modulation of natural cytotoxicity by alloantibodies. IV. A comparative study of the activation of mouse spleen cell cytotoxicity by anti H-2 antisera, interferon and mitogens. Cell Immunol. 63:28–41.
  • Saxena RK, Saxena QB, Alder WH. 1982. Defective T-cell response in beige mutant mice. Nature. 295:240–241.
  • Saxena RK, Saxena QB, Alder WH. 1984. Interleukin-2 activation of natural killer activity in spleen cells from old and young mice. Immunology. 51:719–726.
  • Saxena RK, Saxena QB, Collins GD, Adler WH. 1983. Augmentation of spleen natural killer activity in mice treated with IL-2 preparation. Indian J Exp Biol. 21:54–58.
  • Saxena RK, Gilmour MI, Hays MD. 2008. Isolation and quantitative estimation of diesel exhaust and carbon black particles ingested by lung epithelial cells and alveolar macrophages in vitro. BioTechniques. 44:799–805.
  • Saxena RK, Wiessman D, Saxena QB, Simpson J, Lewis DM. 2002. Kinetics of changes in lymphocyte sub-populations in mouse lungs after intrapulmonary infection with M. bovis (Bacillus Calmette-Guerin) and identity of cells responsible for IFNγ responses. Clin Exp Immunol. 128:405–410.
  • Saxena RK, Williams W, McGee JK, Daniels MJ, Boykin E, Gilmour MI. 2007. Enhanced in vitro and in vivo toxicity of poly-dispersed acid-functionalized single walled carbon nanotubes. Nanotoxicology. 1:291–300.
  • Shvedova A, Fabisiak J, Kisin E, Murray A, Roberts J, Tyurina Y, Antonini J, Feng W, Kommineni C, Reynolds J, et al. 2008. Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity. Am J Respir Cell Mol Biol. 38:579–590.
  • Tong H, McGee JK, Saxena RK, Kodavanti UP, Devlin RB, Gilmour MI. 2009. Influence of acid functionalization on the cardiopulmonary toxicity of carbon nanotubes and carbon black particles in mice. Toxicol Appl Pharmacol. 239:224–232.
  • Valentini F, Carbone M, Palleschi G. 2013. Carbon nanostructured materials for applications in nano-medicine, cultural heritage, and electrochemical biosensors. Anal Bioanal Chem. 405:451–465.
  • Walling BE, Kuang Z, Hao Y, Estrada D, Wood JD, Lian F, Miller LA, Shah AB, Jeffries JL, Haasch RT, et al. 2013. Helical carbon nanotubes enhance the early immune response and inhibit macrophage-mediated phagocytosis of Pseudomonas aeruginosa. PLoS One. 8:e80283.
  • Wang J, Sun RH, Zhang N, Nie H, Liu JH, Wang JN, Wang H, Liu Y. 2009. Multi-walled carbon nanotubes do not impair immune functions of dendritic cells. Carbon. 47:1752–1760.
  • Zhang Y, Petibone D, Xu Y, Mahmood M, Karmakar A, Casciano D, Ali S, Biris AS. 2014. Toxicity and efficacy of carbon nanotubes and graphene: the utility of carbon-based nano-particles in nanomedicine. Drug Metab Rev. 46:232–246.
  • Zhao L, Gao X, Peng Y, Joyee AG, Bai H, Wang S, Yang J, Zhao W, Yang X. 2011. Differential modulating effect of natural killer (NK) T-cells on IFNγ production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection. Immunology. 134:172–184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.